ZA200609638B - Polymer conjugate releasable under mild thiolytic conditions - Google Patents

Polymer conjugate releasable under mild thiolytic conditions

Info

Publication number
ZA200609638B
ZA200609638B ZA200609638A ZA200609638A ZA200609638B ZA 200609638 B ZA200609638 B ZA 200609638B ZA 200609638 A ZA200609638 A ZA 200609638A ZA 200609638 A ZA200609638 A ZA 200609638A ZA 200609638 B ZA200609638 B ZA 200609638B
Authority
ZA
South Africa
Prior art keywords
under mild
polymer conjugate
releasable under
thiolytic conditions
mild thiolytic
Prior art date
Application number
ZA200609638A
Other languages
English (en)
Inventor
Zalipsky Samuel
Subramony Paramjeet
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA200609638B publication Critical patent/ZA200609638B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02Monothiocarbonic acids; Derivatives thereof
    • C07C329/04Esters of monothiocarbonic acids
    • C07C329/10Esters of monothiocarbonic acids having sulfur atoms of thiocarbonic groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039Coumarin dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056Peptides, proteins, polyamino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02Monothiocarbonic acids; Derivatives thereof
    • C07C329/04Esters of monothiocarbonic acids
    • C07C329/08Esters of monothiocarbonic acids having sulfur atoms of thiocarbonic groups bound to carbon atoms of rings other than six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyethers (AREA)
ZA200609638A 2004-04-21 2005-04-20 Polymer conjugate releasable under mild thiolytic conditions ZA200609638B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56456504P 2004-04-21 2004-04-21

Publications (1)

Publication Number Publication Date
ZA200609638B true ZA200609638B (en) 2008-02-27

Family

ID=37450607

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609638A ZA200609638B (en) 2004-04-21 2005-04-20 Polymer conjugate releasable under mild thiolytic conditions

Country Status (11)

Country Link
US (1) US20050265925A1 (xx)
EP (1) EP1748795A1 (xx)
KR (1) KR20070010175A (xx)
CN (1) CN1997399A (xx)
AU (1) AU2005238015A1 (xx)
CA (1) CA2562527A1 (xx)
IL (1) IL178561A0 (xx)
MX (1) MXPA06012144A (xx)
NO (1) NO20065270L (xx)
WO (1) WO2005105154A1 (xx)
ZA (1) ZA200609638B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100255050A1 (en) * 2007-07-24 2010-10-07 James Klein Leonard Polyethylene Based Bioactive Agents
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
BRPI0921687A8 (pt) 2008-11-03 2022-11-08 Syntarga Bv Composto , conjugado , uso de um composto , composição farmacêutica, processo para preparar uma composição famacêutica , método para tratar um mamífero em necessidade do mesmo ,e, método para tratar ou prevenir um tumor em um mamífero.
PL3056203T3 (pl) 2010-04-21 2018-06-29 Syntarga B.V. Koniugaty analogów CC-1065 i łączników dwufunkcyjnych
ES2755719T3 (es) 2012-04-05 2020-04-23 Nerviano Medical Sciences Srl Nuevos agentes alquilantes
JP6251236B2 (ja) 2012-04-05 2017-12-20 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 癌を治療するための官能性チエノ−インドール誘導体
CN104755482B (zh) 2012-10-30 2017-04-26 内尔维阿诺医学科学有限公司 官能化的9‑溴‑喜树碱衍生物
US10266547B2 (en) 2013-09-25 2019-04-23 Nerviano Medical Sciences S.R.L. Thieno[2,3-e]indole derivatives as new antitumor agents
PT3092010T (pt) 2014-01-10 2018-09-28 Synthon Biopharmaceuticals Bv Método para purificação de conjugados anticorpo-fármaco ligados por cys
RU2715902C2 (ru) 2014-11-05 2020-03-04 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Функционализированные производные морфолинилантрациклина
EP3604386B1 (en) 2017-03-30 2022-04-06 NOF Corporation Degradable polyethylene glycol derivative having disulfide linker

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US5103556A (en) * 1988-05-05 1992-04-14 Circon Corporation Method of manufacturing an electrohydraulic probe
US4902502A (en) * 1989-01-23 1990-02-20 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
ES2247656T3 (es) * 1989-04-19 2006-03-01 Enzon, Inc. Un proceso para formar un polipeptido modificado que comprende un polipeptido y un oxido de polialquileno.
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
WO1998016201A1 (en) * 1996-10-11 1998-04-23 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method
US6214330B1 (en) * 1998-07-13 2001-04-10 Enzon, Inc. Coumarin and related aromatic-based polymeric prodrugs
EP1880736A1 (en) * 1999-04-23 2008-01-23 Alza Corporation Releasable linkage and composition containing same

Also Published As

Publication number Publication date
US20050265925A1 (en) 2005-12-01
KR20070010175A (ko) 2007-01-22
MXPA06012144A (es) 2007-01-31
CN1997399A (zh) 2007-07-11
AU2005238015A1 (en) 2005-11-10
CA2562527A1 (en) 2005-11-10
WO2005105154A8 (en) 2007-02-15
NO20065270L (no) 2007-01-17
EP1748795A1 (en) 2007-02-07
WO2005105154A1 (en) 2005-11-10
IL178561A0 (en) 2007-02-11

Similar Documents

Publication Publication Date Title
IL178561A0 (en) Polymer conjugate releasable under mild thiolytic conditions
HK1198485A1 (en) Molecular conjugate
IL247788A0 (en) Conjugated medicinal composition
EP1816192A4 (en) RNA-PUROMYCIN-PROTEIN CONJUGATE CONSTRUCTION TIE
IL191941A0 (en) Conjugate vaccines
GB2435907B (en) Hydraulic service module
IL183582A0 (en) Polymer conjugates and methods for the preparation thereof
EP1742613A4 (en) NETWORKED AMINPOLYMERS
EP1725596A4 (en) BRANCHED POLYPHENYLENE POLYMERS
GB2427866B (en) Pentathienyl-fluorene copolymer
EP1734988A4 (en) INTERFERON BETA-polymer
GB2412111B (en) Polymeric void-board
EP1968603A4 (en) THERAPEUTIC AMINARYLSULFONAMIDE CONJUGATE COMPOUNDS
EP1718335A4 (en) CONJUGATES OF DRUGS
HK1138799A1 (en) Polyethylene glycol-g-csf conjugate
EP1736501A4 (en) CONJUGATED FUNCTIONAL NUCLEIC ACID-PEG
AU2003901897A0 (en) Conjugate
GB0408102D0 (en) Total dissolved solids
GB0708864D0 (en) Cytokine Conjugate
GB0418387D0 (en) Vehicle displacement apparatus
EP2092343A4 (en) DETECTION CONJUGATE
GB0424777D0 (en) Graft polymers
GB0408483D0 (en) Ostomy bag
GB0411526D0 (en) Conjugate
ZA200805298B (en) Conjugate vaccines